YHB Investment Advisors Inc. Invests $609,000 in Humana Inc. (NYSE:HUM)

YHB Investment Advisors Inc. bought a new position in Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 2,301 shares of the insurance provider's stock, valued at approximately $609,000.

A number of other institutional investors also recently bought and sold shares of the stock. LFA Lugano Financial Advisors SA lifted its holdings in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new stake in shares of Humana during the 4th quarter valued at $33,000. Riverview Trust Co purchased a new position in shares of Humana during the 1st quarter valued at $34,000. Garde Capital Inc. bought a new position in Humana in the 1st quarter worth $36,000. Finally, Transce3nd LLC bought a new position in Humana in the 4th quarter worth $38,000. 92.38% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Mizuho boosted their price objective on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Truist Financial set a $280.00 price target on Humana and gave the stock a "hold" rating in a report on Tuesday, June 17th. Wall Street Zen cut Humana from a "buy" rating to a "hold" rating in a report on Saturday, June 14th. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a report on Thursday, May 1st. Finally, Robert W. Baird raised their price objective on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average target price of $280.76.

Humana Stock Up 1.7%

NYSE HUM opened at $238.61 on Wednesday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The firm has a market capitalization of $28.80 billion, a price-to-earnings ratio of 16.87, a PEG ratio of 1.77 and a beta of 0.43. The company has a fifty day moving average of $243.81 and a two-hundred day moving average of $260.20.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business's revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the business earned $7.23 EPS. On average, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.48%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.